Fludrocortisone Acetate — Drug Intelligence | 9 EU Trials

Filter these 9 trials by condition, phase, country and more.

Open in Search →

9 Registered trials

7 Recruiting

1 Completed trials

4 Sponsors

21 Countries

Phase III

Phase II/III

Phase II

Phase I/II

Phase IV

Phase III: 4 Phase II/III: 1 Phase II: 1 Phase I/II: 2 Phase IV: 1

Oversight events:

35 temporary halts 1 urgent safety measure across 4 trials

View oversight register →

Indications tested

Critical illness 1 Prostate cancer metastatic 1

Sponsors using this IMP

Merck Sharp & Dohme LLC 5 Assistance Publique Hopitaux De Paris 2 Centre Hospitalier Universitaire De Nantes 1 H.A.C. Pharma 1

All trials

9 total

PALETTE - Trial for personalisation of sepsis treatment in children and adults Pending

2025-521371-31-00 Phase II 1 country Assistance Publique Hopitaux De Paris
A clinical study of opevesostat and standard hormone therapy in people with prostate cancer (MK-5684-004) Recruiting

2023-504957-11-00 Phase III 15 countries Merck Sharp & Dohme LLC
A clinical study of MK-5684 in people with certain solid tumors (MK-5684-015) Recruiting

2024-519563-18-00 Phase II/III 1 country Merck Sharp & Dohme LLC
A clinical study of ifinatamab deruxtecan to treat metastatic prostate cancer (MK 2400 01A) Recruiting

2024-516036-94-00 Phase I/II 7 countries Merck Sharp & Dohme LLC
Study of MK-5684-based Therapies in Advanced Prostate Cancer Recruiting

2023-506288-33-00 Phase I/II 8 countries Merck Sharp & Dohme LLC
A clinical trial comparing a new treatment (MK-5684) to approved medication for advanced prostate cancer after prior hormonal therapy and ch… Recruiting

2023-504899-25-00 Phase III 14 countries Merck Sharp & Dohme LLC
FLUCLORIC - Randomized multicentric Phase III study comparing the efficacy of two reduced intensity conditioning regimens (clofarabine/busul… Recruiting

2022-502019-12-00 Phase III 1 country Centre Hospitalier Universitaire De Nantes
Evaluation of efficacy and tolerance of fludrocortisone (Flucortac) in the treatment of neurogenic orthostatic hypotension Recruiting

2024-517841-16-00 Phase IV 1 country H.A.C. Pharma
Hydrocortisone and Fludrocortisone for Critical Illness-related Corticosteroid Insufficiency Ended

2024-516021-32-00 Phase III 1 country Assistance Publique Hopitaux De Paris

Showing 1–9 of 9 trials

← All drugs A–Z